SciSparc (SPRC) Receivables - Other (2016 - 2025)
SciSparc (SPRC) posted Receivables - Other of $289000.0 for Q4 2025, up 489.8% sequentially from $49000.0 in Q2 2025, and down 93.16% YoY from $4.2 million in Q4 2024.
SciSparc (SPRC) Receivables - Other (2016 - 2025) Analysis & Trends
SciSparc has reported Receivables - Other for 9 years, with the latest figure at $289000.0 in Q4 2025.
- Quarterly Receivables - Other fell 93.16% year-over-year to $289000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $289000.0 (down 93.16% YoY) and the FY2025 annual result came in at $289000.0, down 93.16% from the prior year.
- Receivables - Other climbed to $289000.0 in Q4 2025 per SPRC's latest filing, from $49000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $4.2 million in Q4 2024 and troughed at $49000.0 in Q2 2025.
- A 5-year average of $1.0 million and a median of $581000.0 in 2022 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2021 and 2022: Receivables - Other surged 1268.31% in 2021, then sank 94.77% in 2022.
- Over 5 years, Receivables - Other stood at $2.5 million in 2021, then tumbled by 94.77% to $131000.0 in 2022, then jumped by 312.21% to $540000.0 in 2023, then surged by 682.22% to $4.2 million in 2024, then tumbled by 93.16% to $289000.0 in 2025.
- According to Business Quant data, Receivables - Other over the past three periods registered $289000.0, $49000.0, and $4.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | SciSparc | 836,385.99 | 836,385.99 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 289,000.00 |
| Dec 31, 2025 | 289,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Dec 31, 2024 | 4.22 Mn |
| Dec 31, 2024 | 4.22 Mn |
| Jun 30, 2024 | 190,000.00 |
| Jun 30, 2024 | 190,000.00 |
| Dec 31, 2023 | 540,000.00 |
| Dec 31, 2023 | 540,000.00 |
| Jun 30, 2023 | 815,000.00 |
| Jun 30, 2023 | 815,000.00 |
| Dec 31, 2022 | 131,000.00 |
| Dec 31, 2022 | 131,000.00 |
| Jun 30, 2022 | 622,000.00 |
| Jun 30, 2022 | 622,000.00 |
| Dec 31, 2021 | 2.50 Mn |
| Dec 31, 2021 | 2.50 Mn |
| Jun 30, 2021 | 731,000.00 |
| Jun 30, 2021 | 731,000.00 |